Search Results - "Song, Moo Kon"

Counter-Therapeutic Strategies for Resistance of FLT3 Inhibitors in Acute Myeloid Leukemia.

Authors: Song, Moo-Kon¹ (AUTHOR)

Source: Cells (2073-4409). Oct2025, Vol. 14 Issue 19, p1526. 16p.

Radioimmunotherapy with ¹³¹I‐rituximab for patients with relapsed or refractory follicular or mantle cell lymphoma.

Authors: Jang, Yoon Jung Lim, Sang Moo Lee, Inki et al.

Source: Asia Pacific Journal of Clinical Oncology. Dec2023, Vol. 19 Issue 6, p690-696. 7p.

Clinical Efficacies of FLT3 Inhibitors in Patients with Acute Myeloid Leukemia.

Authors: Song, Moo-Kon Park, Byeong-Bae Uhm, Ji-Eun

Source: International Journal of Molecular Sciences. Oct2022, Vol. 23 Issue 20, p12708-N.PAG. 19p.

Prognostic significance of the Bcl-2 negative germinal centre in patients with diffuse large B cell lymphoma treated with R-CHOP.

Authors: Song, Moo-Kon Chung, Joo-Seop Shin, Dong-Hoon et al.

Source: Leukemia & Lymphoma. Jan2009, Vol. 50 Issue 1, p54-61. 8p. 3 Charts, 4 Graphs.

Understanding Splenomegaly in Myelofibrosis: Association with Molecular Pathogenesis.

Authors: Song, Moo-Kon Park, Byeong-Bae Uhm, Ji-Eun

Source: International Journal of Molecular Sciences. Mar2018, Vol. 19 Issue 3, p898. 11p. 1 Diagram, 2 Charts.

Clinical outcome and prognosis of patients with primary sinonasal tract diffuse large B-cell lymphoma treated with rituximab-cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy: a study by the Consortium for Improving Survival of Lymphoma

Authors: Lee, Gyeong-Won Go, Se-Il Kim, Seok-Hyun et al.

Source: Leukemia & Lymphoma. Apr2015, Vol. 56 Issue 4, p1020-1026. 7p.

MPL W515 L/K mutations in myeloproliferative neoplasms.

Authors: Eldeweny, Sohaila Ibrahim, Hosny Elsayed, Ghada et al.

Source: Egyptian Journal of Medical Human Genetics. 12/12/2019, Vol. 20 Issue 1, p1-7. 7p.

Primary myelofibrosis: spectrum of imaging features and disease-related complications.

Authors: Oon, Sheng Fei Singh, Dalveer Tan, Teng Han et al.

Source: Insights into Imaging. 8/7/2019, Vol. 10 Issue 1, p1-14. 14p.

Targeted Therapeutic Approach Based on Understanding of Aberrant Molecular Pathways Leading to Leukemic Proliferation in Patients with Acute Myeloid Leukemia.

Authors: Song, Moo-Kon Park, Byeong-Bae Uhm, Ji-Eun

Source: International Journal of Molecular Sciences. Jun2021, Vol. 22 Issue 11, p5789. 1p.

Resistance Mechanisms to CAR T-Cell Therapy and Overcoming Strategy in B-Cell Hematologic Malignancies.

Authors: Song, Moo-Kon Park, Byeong-Bae Uhm, Ji-Eun

Source: International Journal of Molecular Sciences. Oct2019, Vol. 20 Issue 20, p5010. 1p. 1 Color Photograph, 2 Charts.

Understanding Immune Evasion and Therapeutic Targeting Associated with PD-1/PD-L1 Pathway in Diffuse Large B-cell Lymphoma.

Authors: Song, Moo-Kon Park, Byeong-Bae Uhm, Jieun

Source: International Journal of Molecular Sciences. Mar2019, Vol. 20 Issue 6, p1326-1326. 1p. 1 Diagram, 2 Charts.

Busulfan-containing conditioning regimens are optimal preparative regimens for autologous stem cell transplant in patients with diffuse large B-cell lymphoma.

Authors: Shin, Ho-Jin Lee, Won-Sik Lee, Ho-Seop et al.

Source: Leukemia & Lymphoma. Nov2014, Vol. 55 Issue 11, p2490-2496. 7p.

Measurement of tumor volume by PET to evaluate prognosis in patients with head and neck cancer treated by chemo-radiation therapy.

Authors: Seol, Young Mi Kwon, Bo Ran Song, Moo Kon et al.

Source: Acta Oncologica. Mar2010, Vol. 49 Issue 2, p201-208. 8p. 4 Charts, 5 Graphs.

Incidence and Prognostic Impact of DNMT3A Mutations in Korean Normal Karyotype Acute Myeloid Leukemia Patients.

Authors: Park, Sang Hyuk Choi, Jae-Cheol Kim, Shine Young et al.

Source: BioMed Research International. 1/11/2015, Vol. 2015, p1-11. 11p.

MiR-214 prevents the progression of diffuse large B-cell lymphoma by targeting PD-L1.

Authors: Sun JR Zhang X Zhang Y

Source: Cellular & molecular biology letters [Cell Mol Biol Lett] 2019 Dec 04; Vol. 24, pp. 68. Date of Electronic Publication: 2019 Dec 04 (Print Publication: 2019).

Publication Type: Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 9607427 Publication Model: eCollection Cited Medium: Internet ISSN: 1689-1392 (Electronic) Linking ISSN: 14258153 NLM ISO Abbreviation: Cell Mol Biol Lett Subsets: MEDLINE